Singapore markets closed

Philip Morris International Inc. (PM)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
98.94-0.53 (-0.53%)
As of 01:30PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close99.47
Open99.79
Bid98.89 x 800
Ask98.90 x 800
Day's range98.67 - 100.06
52-week range85.64 - 112.48
Volume1,051,158
Avg. volume5,188,640
Market cap153.798B
Beta (5Y monthly)0.64
PE ratio (TTM)16.97
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield5.00 (5.14%)
Ex-dividend date30 Jun 2022
1y target estN/A
  • Motley Fool

    Want Growing Passive Income? Check Out This Ultra-High-Yield Dividend Stock

    Shares of tobacco company Philip Morris International (NYSE: PM) have gained almost 5% in 2022. Philip Morris International shared results for the second quarter ended June 30 late last month. Philip Morris International recorded $7.8 billion in adjusted net revenue in the second quarter, which was down 0.1% over the year-ago period.

  • Motley Fool

    Altria or Philip Morris International: Which Stock Should You Buy Now?

    Tobacco stocks are a longtime favorite of dividend investors, and sister companies Altria Group (NYSE: MO) and Philip Morris International (NYSE: PM) dominate the industry. Since Altria spun off Philip Morris more than a decade ago, the two companies have taken different approaches to ready their companies for a future where cigarettes aren't their main revenue source. Altria sells tobacco and nicotine products in the United States, headlined by the Marlboro brand of cigarettes.

  • Motley Fool

    3 Reasons to Buy Philip Morris International

    With the S&P 500 down 14% year to date, 2022 hasn't been kind to many stock market investors. As a tobacco company, Philip Morris is highly shielded from these challenges because nicotine products are habit-forming, and consumers will likely continue buying them in a weak economy. While these headwinds have hurt U.S.-focused tobacco companies like Altria Group (down 7% this year), Philip Morris targets international markets outside the U.S., so it has little to fear from American regulation.